Qilu Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?
QILU has twenty-one approved drugs.
Drugs and US Patents for Qilu
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Qilu | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate | TABLET;ORAL | 209498-002 | Mar 2, 2018 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Qilu | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 209333-001 | May 20, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Qilu | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 209217-001 | Oct 17, 2018 | AP | RX | No | Yes | See Plans and Pricing | See Plans and Pricing | ||||
Qilu Pharm Hainan | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 204368-003 | Jun 7, 2016 | RX | No | Yes | See Plans and Pricing | See Plans and Pricing | |||||
Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-002 | Jun 29, 2016 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Qilu | OLANZAPINE | olanzapine | TABLET;ORAL | 204319-003 | Jan 27, 2016 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Qilu Pharm Hainan | DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 212826-001 | Apr 12, 2021 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.